Osteopore Ltd - Asset Resilience Ratio

Latest as of June 2025: 43.09%

Osteopore Ltd (OSX) has an Asset Resilience Ratio of 43.09% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read OSX liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

AU$1.81 Million
≈ $1.28 Million USD Cash + Short-term Investments

Total Assets

AU$4.19 Million
≈ $2.97 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how Osteopore Ltd's Asset Resilience Ratio has changed over time. See OSX net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Osteopore Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see OSX market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$1.77 Million 42.31%
Short-term Investments AU$32.73K 0.78%
Total Liquid Assets AU$1.81 Million 43.09%

Asset Resilience Insights

  • Very High Liquidity: Osteopore Ltd maintains exceptional liquid asset reserves at 43.09% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Osteopore Ltd Industry Peers by Asset Resilience Ratio

Compare Osteopore Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Teleflex Incorporated
NYSE:TFX
Medical Instruments & Supplies 4.50%
Touchstone International Medical Science Co Ltd
SHG:688013
Medical Instruments & Supplies 37.86%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%
Crossject
PA:ALCJ
Medical Instruments & Supplies 1.31%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%

Annual Asset Resilience Ratio for Osteopore Ltd (2018–2024)

The table below shows the annual Asset Resilience Ratio data for Osteopore Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.18% AU$5.75K
≈ $4.07K
AU$3.13 Million
≈ $2.22 Million
+0.02pp
2023-12-31 0.17% AU$5.56K
≈ $3.93K
AU$3.34 Million
≈ $2.37 Million
-0.35pp
2022-12-31 0.51% AU$18.52K
≈ $13.11K
AU$3.62 Million
≈ $2.56 Million
-2.85pp
2021-12-31 3.36% AU$201.62K
≈ $142.66K
AU$6.01 Million
≈ $4.25 Million
+3.20pp
2020-12-31 0.16% AU$16.40K
≈ $11.60K
AU$10.25 Million
≈ $7.25 Million
-0.21pp
2019-12-31 0.37% AU$15.79K
≈ $11.17K
AU$4.28 Million
≈ $3.03 Million
+0.18pp
2018-12-31 0.18% AU$9.94K
≈ $7.03K
AU$5.40 Million
≈ $3.82 Million
--
pp = percentage points

About Osteopore Ltd

AU:OSX Australia Medical Instruments & Supplies
Market Cap
$2.39 Million
AU$3.38 Million AUD
Market Cap Rank
#29499 Global
#1737 in Australia
Share Price
AU$0.01
Change (1 day)
+16.67%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$15.65
About

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates spe… Read more